We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Moelis & Co. Stock Up 33.5% in 3 Months: Is it a Lucrative Bet?
Read MoreHide Full Article
Key Takeaways
{\"0\":\"Moelis & Co. stock jumped 33.5% in three months, outpacing the sector and the S&P 500.\",\"1\":\"Fed rate cuts are expected to boost M&A volumes, aiding MC\'s advisory revenues.\",\"2\":\"MC shows strong growth, broad diversification and consistent shareholder payouts.\"}
In the past three months, Moelis & Co. (MC - Free Report) shares have demonstrated strong performance. The stock has soared 33.5%, outperforming the industry, the Finance sector and the S&P 500 index. Further, it has fared better than its peer, Lazard Inc. (LAZ - Free Report) , while underperforming Evercore, Inc. (EVR - Free Report) in the same time frame.
MC’s Three-Month Price Performance
Image Source: Zacks Investment Research
This underscores positive market sentiments and confidence in Moelis & Co.’s financial health and prospects. Let’s find out whether MC’s current rally has legs or it's time to sell.
Factors Supporting Moelis & Co. Stock
Federal Reserve Interest Rate Cut to Aid M&A: On Sept. 17, 2025, the Federal Reserve lowered rates by 25 bps for the first time this year, citing persistent inflation and a weakening labor market under the Trump administration’s tariff regime. The Fed also signaled two additional cuts before year-end.
Lower borrowing costs and supportive equity valuations should drive stronger mergers and acquisitions (M&A) volumes, enhancing Moelis & Co’s advisory revenues. While looser credit conditions may temporarily dampen restructuring activity, Moelis’s diversified advisory platform positions it to capture upside from increased domestic transactions and sector-specific consolidation.
Solid Organic Performance: Moelis & Co. has been demonstrating robust organic performance. Despite revenue declines in 2019, 2022, and 2023 due to cyclical softness in M&A completions, the company achieved a robust 10% compound annual growth rate (CAGR) over the five years ending in 2024. That momentum carried into the first half of 2025, supported by higher average fees per deal and an ongoing surge in global restructuring activity as highly leveraged companies adapt to a changing rate environment.
This, along with efforts to boost geographical expansion and capital markets business, will likely support the company’s revenues in the quarters ahead.
Business Diversification: MC has significantly diversified its business operations across a broad range of sectors and regions. Further, the company doesn’t have substantial client concentration, with the top 10 transactions representing less than 25% of total revenues.
Additionally, its collaborations in Japan and Mexico, as well as its non-controlling stake in Moelis Australia Limited, offer significant support. With more than $5.1 trillion in advised transactions since inception, global expansion and diversification are expected to continue supporting its profitability.
Encouraging Capital Distributions: Moelis & Co. has been engaged in meaningful capital distributions. Since 2014, the firm has announced 11 dividend increases, with the most recent one announced in February 2025.
In 2021, the company announced an increase in its share repurchase authorization by $100 million. As of June 30, 2025, it had roughly $61.1 million in authorization remaining.
Given a debt-free balance sheet, the company’s capital distributions seem sustainable going forward.
Analysts Bullish on MC’s Prospects
The Zacks Consensus Estimate for Moelis & Co.’s 2025 and 2026 revenues suggests a year-over-year increase of 24% and 13.5%, respectively.
Sales Estimates
Image Source: Zacks Investment Research
Also, the consensus estimate for MC’s earnings suggests a 37.9% and 28.7% jump in 2025 and 2026, respectively. Earnings estimates for both years have been revised upward over the past 30 days.
Estimate Revision
Image Source: Zacks Investment Research
Moelis & Co. Stock Trading at a Premium
MC stock is currently trading at a 12-month forward price-to-earnings (P/E) of 24.92X. This is above the industry’s 14.95X and shows that the stock is expensive at present.
12-month Forward Price-to-Earnings Ratio (P/E F12M)
Image Source: Zacks Investment Research
MC stock is expensive compared with Evercore and Lazard. At present, Evercore has a P/EF12M of 17.74X and Lazard’s P/EF12M is 15.96X.
Are MC Shares Worth Betting On?
Moelis & Co.'s robust organic growth, business restructuring initiatives and diversification efforts will drive growth. Moreover, bullish analyst sentiments are another positive.
Additionally, Moelis & Co.’s growth initiatives have helped generate higher returns. This is demonstrated by the company’s return on equity (ROE) of 42.72% compared with the industry’s ROE of 12.06%.
Return on Equity
Image Source: Zacks Investment Research
On the other hand, Evercore has an ROE of 27.29% and Lazard has an ROE of 34.33%, reflecting that MC is efficient in capital allocation activities compared with its peers.
However, a steady rise in expenses is a headwind. The company recorded a five-year CAGR of 10.1% (ended 2024), mainly due to higher compensation costs. The uptrend continued in the first six months of 2025. As the company expands its operations into new sectors and products, overall costs are expected to remain elevated.
Further, given rising geopolitical risks, foreign currency fluctuations and the global impact of tariff policies, MC may witness subdued overseas revenues (22.6% of total revenues in the first half of 2025), which will likely weigh on its growth to some extent.
Nonetheless, relatively lower rates on the back of interest rate cuts are likely to bolster M&A activities. Also, a solid balance sheet will likely continue to aid enhanced capital distributions. While valuation remains stretched, higher growth prospects justifies it. Thus, MC remains an attractive investment pick for investors.
Image: Shutterstock
Moelis & Co. Stock Up 33.5% in 3 Months: Is it a Lucrative Bet?
Key Takeaways
In the past three months, Moelis & Co. (MC - Free Report) shares have demonstrated strong performance. The stock has soared 33.5%, outperforming the industry, the Finance sector and the S&P 500 index. Further, it has fared better than its peer, Lazard Inc. (LAZ - Free Report) , while underperforming Evercore, Inc. (EVR - Free Report) in the same time frame.
MC’s Three-Month Price Performance
Image Source: Zacks Investment Research
This underscores positive market sentiments and confidence in Moelis & Co.’s financial health and prospects. Let’s find out whether MC’s current rally has legs or it's time to sell.
Factors Supporting Moelis & Co. Stock
Federal Reserve Interest Rate Cut to Aid M&A: On Sept. 17, 2025, the Federal Reserve lowered rates by 25 bps for the first time this year, citing persistent inflation and a weakening labor market under the Trump administration’s tariff regime. The Fed also signaled two additional cuts before year-end.
Lower borrowing costs and supportive equity valuations should drive stronger mergers and acquisitions (M&A) volumes, enhancing Moelis & Co’s advisory revenues. While looser credit conditions may temporarily dampen restructuring activity, Moelis’s diversified advisory platform positions it to capture upside from increased domestic transactions and sector-specific consolidation.
Solid Organic Performance: Moelis & Co. has been demonstrating robust organic performance. Despite revenue declines in 2019, 2022, and 2023 due to cyclical softness in M&A completions, the company achieved a robust 10% compound annual growth rate (CAGR) over the five years ending in 2024. That momentum carried into the first half of 2025, supported by higher average fees per deal and an ongoing surge in global restructuring activity as highly leveraged companies adapt to a changing rate environment.
This, along with efforts to boost geographical expansion and capital markets business, will likely support the company’s revenues in the quarters ahead.
Business Diversification: MC has significantly diversified its business operations across a broad range of sectors and regions. Further, the company doesn’t have substantial client concentration, with the top 10 transactions representing less than 25% of total revenues.
Additionally, its collaborations in Japan and Mexico, as well as its non-controlling stake in Moelis Australia Limited, offer significant support. With more than $5.1 trillion in advised transactions since inception, global expansion and diversification are expected to continue supporting its profitability.
Encouraging Capital Distributions: Moelis & Co. has been engaged in meaningful capital distributions. Since 2014, the firm has announced 11 dividend increases, with the most recent one announced in February 2025.
In 2021, the company announced an increase in its share repurchase authorization by $100 million. As of June 30, 2025, it had roughly $61.1 million in authorization remaining.
Given a debt-free balance sheet, the company’s capital distributions seem sustainable going forward.
Analysts Bullish on MC’s Prospects
The Zacks Consensus Estimate for Moelis & Co.’s 2025 and 2026 revenues suggests a year-over-year increase of 24% and 13.5%, respectively.
Sales Estimates
Image Source: Zacks Investment Research
Also, the consensus estimate for MC’s earnings suggests a 37.9% and 28.7% jump in 2025 and 2026, respectively. Earnings estimates for both years have been revised upward over the past 30 days.
Estimate Revision
Image Source: Zacks Investment Research
Moelis & Co. Stock Trading at a Premium
MC stock is currently trading at a 12-month forward price-to-earnings (P/E) of 24.92X. This is above the industry’s 14.95X and shows that the stock is expensive at present.
12-month Forward Price-to-Earnings Ratio (P/E F12M)
Image Source: Zacks Investment Research
MC stock is expensive compared with Evercore and Lazard. At present, Evercore has a P/EF12M of 17.74X and Lazard’s P/EF12M is 15.96X.
Are MC Shares Worth Betting On?
Moelis & Co.'s robust organic growth, business restructuring initiatives and diversification efforts will drive growth. Moreover, bullish analyst sentiments are another positive.
Additionally, Moelis & Co.’s growth initiatives have helped generate higher returns. This is demonstrated by the company’s return on equity (ROE) of 42.72% compared with the industry’s ROE of 12.06%.
Return on Equity
Image Source: Zacks Investment Research
On the other hand, Evercore has an ROE of 27.29% and Lazard has an ROE of 34.33%, reflecting that MC is efficient in capital allocation activities compared with its peers.
However, a steady rise in expenses is a headwind. The company recorded a five-year CAGR of 10.1% (ended 2024), mainly due to higher compensation costs. The uptrend continued in the first six months of 2025. As the company expands its operations into new sectors and products, overall costs are expected to remain elevated.
Further, given rising geopolitical risks, foreign currency fluctuations and the global impact of tariff policies, MC may witness subdued overseas revenues (22.6% of total revenues in the first half of 2025), which will likely weigh on its growth to some extent.
Nonetheless, relatively lower rates on the back of interest rate cuts are likely to bolster M&A activities. Also, a solid balance sheet will likely continue to aid enhanced capital distributions. While valuation remains stretched, higher growth prospects justifies it. Thus, MC remains an attractive investment pick for investors.
Currently, MC sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.